Commonly Prescribed Acid Reflux Medication Not Helpful for Children With Asthma

Published Online: Friday, July 20, 2012
Follow Pharmacy_Times:
Acid reflux is common among children with asthma, and in recent years there has been a dramatic increase in prescriptions of proton pump inhibitors (PPIs) for children with asthma. This episode of the JAMA Report discusses a controlled study in which pediatric asthma patients without acid reflux symptoms were given either placebo or a PPI in addition to corticosteroids. The study found that PPI treatment did not improve asthma symptoms and may come with risks, including increased chance of infection.
 
To read our article on the study, click here.

Related Articles
The FDA is currently reviewing Teva’s reslizumab treatment for adult and adolescent asthmatics with symptoms inadequately controlled by inhaled corticosteroid (ICS) regimens.
An FDA advisory committee has unanimously recommended approval for GlaxoSmithKline’s mepolizumab severe asthma treatment in adults, but not adolescents.
While some patients may take soy supplements to manage their asthma, a new study suggests there is no solid evidence of improved lung function or clinical outcomes from the supplementation.
Clinical guidelines and government agencies are increasingly encouraging clinicians to consider patients’ treatment preferences when chronic disease is present.
Latest Issues
$auto_registration$